Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WANDA S GUMBS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1679831226
CMS profile
1354704
Location
ATLANTA, GA

General Payments · PY2018–2019

$702.13

  • Reported across 37 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$359.21

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $359.21 18

By paying entity

PY2019 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $222.42 10
Gilead Sciences, Inc. $77.09 4
Merck Sharp & Dohme Corporation $32.19 2
Allergan Inc. $14.58 1
Novo Nordisk AS $12.93 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $342.92 19
PY2019 $359.21 18

Payment records · PY2019 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Allergan Inc. $14.58 08/28/2019 Food and Beverage Undisputed 01/23/2026 670468065 CMS
Astellas Pharma US Inc $21.93 01/07/2019 Food and Beverage Undisputed 01/23/2026 655587183 CMS
Astellas Pharma US Inc $21.99 02/06/2019 Food and Beverage Undisputed 01/23/2026 655587189 CMS
Astellas Pharma US Inc $23.67 03/08/2019 Food and Beverage Undisputed 01/23/2026 655587191 CMS
Astellas Pharma US Inc $22.99 04/05/2019 Food and Beverage Undisputed 01/23/2026 655587195 CMS
Astellas Pharma US Inc $23.01 05/03/2019 Food and Beverage Undisputed 01/23/2026 655587197 CMS
Astellas Pharma US Inc $22.63 06/14/2019 Food and Beverage Undisputed 01/23/2026 655587201 CMS
Astellas Pharma US Inc $17.41 07/16/2019 Food and Beverage Undisputed 01/23/2026 655587203 CMS
Astellas Pharma US Inc $23.82 08/22/2019 Food and Beverage Undisputed 01/23/2026 655587207 CMS
Astellas Pharma US Inc $23.84 09/20/2019 Food and Beverage Undisputed 01/23/2026 655587209 CMS
Astellas Pharma US Inc $21.13 10/18/2019 Food and Beverage Undisputed 01/23/2026 655587213 CMS
Gilead Sciences, Inc. $21.23 04/11/2019 Food and Beverage Undisputed 01/23/2026 681522897 CMS
Gilead Sciences, Inc. $20.90 05/15/2019 Food and Beverage Undisputed 01/23/2026 681522899 CMS
Gilead Sciences, Inc. $22.11 06/12/2019 Food and Beverage Undisputed 01/23/2026 681522901 CMS
Gilead Sciences, Inc. $12.85 07/10/2019 Food and Beverage Undisputed 01/23/2026 681522903 CMS
Merck Sharp & Dohme Corporation $15.45 01/30/2019 Food and Beverage Undisputed 01/23/2026 695252377 CMS
Merck Sharp & Dohme Corporation $16.74 05/17/2019 Food and Beverage Undisputed 01/23/2026 695904003 CMS
Novo Nordisk Inc $12.93 08/21/2019 Food and Beverage Undisputed 01/23/2026 674596931 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.